CVS Health's Dividend Yield Hits 3% Amid Stock Decline
On September 18, CVS Health (CVS) closed at $88.84 after falling roughly 20% from its earlier high of $110.68 in 2026, pushing the dividend yield to nearly 3%. The increase was driven by a drop in stock price rather than an increased payout, raising questions about whether this is a buying opportunity or a warning sign. Despite concerns around financial stability in past years, recent performance suggests improvement. In Q2 2026, CVS generated $5.65 billion in free cash flow—a more than 300% increase from the previous year—allowing for stronger dividend coverage with a payout ratio near 70%. The company has also reduced its net debt to EBITDA ratio to 3.17x and paid down $4 billion in debt this year. CVS is nearing a restart of share repurchases, signaling confidence in the stock's value and financial strength. Management expects at least $8.44 in adjusted EPS for 2027 without relying on capital deployment beyond offsetting dilution.
Tickers: $CVS
Topics: CVS Health debt-to-EBITDA ratio dividend yield free cash flow